Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MHLW Issues Alerts After Student Death With Relenza Prescription

This article was originally published in PharmAsia News

Executive Summary

Japan's Ministry of Health, Labor and Welfare asked patients who take flu drug Relenza (zanamivir) and under-aged flu patients to avoid being alone. The alert was made after a 17-year old high school student's apparent suicide in Nagano Prefecture after being prescribed Relenza. The drug maker GlaxoSmithKline had notified the ministry about the case. Whether the student actually took the drug and there is a relationship between the suicidal behavior and the drug administration are still unknown. The MHLW also called attention to other flu drugs such as amantadine and Tamiflu (oseltamivir). Since many flu cases of this flu season are resistant to Tamiflu, Relenza prescriptions are on the rise. (Click here for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC070858

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel